Bordet Scientific Publications

Bordet Scientific Publications

Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis.

Harb M, Abrassart T, Dewispeleare L, Sidon P, Dirckx N, Trepant AL, Castiaux J, Heimann P, Emile JF, Farhat H

Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis.

Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.

Oaknin A, Monk BJ, de Melo AC, Kim HS, Kim YM, Lisyanskaya AS, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin E, Takahashi S, Ramone D, Maćkowiak-Matejczyk B, Polastro L, Alia EMG, Colombo N, Makarova Y, Goh JC, Hasegawa K, Mora P, Pikiel J, Srivastav R, Rischin D, Rubio MJ, Perez J, Yoo SY, Gao B, Jamil S, Seebach F, Lowy I, Mathias M, Fury MG, Tewari KS

Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Quiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Quiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Quiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Quiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Quiriny M, Rodrigues Vitόria J, Saiselet M, Dom G, De Saint Aubain N, Willemse E, Digonnet A, Dequanter D, Rodriguez A, Andry G, Detours V, Maenhaut C

Description of a New miRNA Signature for the Surgical Management of Thyroid Nodules.

Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F

Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F

Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.

Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet